The present invention discloses compounds of formula (I), or pharmaceutically acceptable salts or prodrugs thereof, which inhibit the poly(ADP-ribose) polymerases (PARP) and therefore are useful for treating diseases, disorders, and conditions related to PARP. The present invention also discloses pharmaceutical compositions comprising a compound of formula (I), and methods of using such compounds to inhibit PARP enzymes, and to treat diseases, disorders, and conditions related to PARP.
本发明公开了式(I)的化合物,或其药学上可接受的盐或前药,其抑制多聚(
ADP-
核糖)聚合酶(
PARP),因此对于治疗与
PARP相关的疾病、紊乱和症状是有用的。本发明还公开了包括式(I)的化合物的药物组合物,以及使用这种化合物抑制
PARP酶,并治疗与
PARP相关的疾病、紊乱和症状的方法。